Christopher N. Johnson

2.6k total citations · 1 hit paper
41 papers, 1.7k citations indexed

About

Christopher N. Johnson is a scholar working on Organic Chemistry, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Christopher N. Johnson has authored 41 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Organic Chemistry, 16 papers in Molecular Biology and 7 papers in Computational Theory and Mathematics. Recurrent topics in Christopher N. Johnson's work include Computational Drug Discovery Methods (7 papers), Catalytic Cross-Coupling Reactions (5 papers) and Ubiquitin and proteasome pathways (4 papers). Christopher N. Johnson is often cited by papers focused on Computational Drug Discovery Methods (7 papers), Catalytic Cross-Coupling Reactions (5 papers) and Ubiquitin and proteasome pathways (4 papers). Christopher N. Johnson collaborates with scholars based in United Kingdom, Switzerland and United States. Christopher N. Johnson's co-authors include Tom D. Heightman, David J. Wright, Honorine Lebraud, Daniel A. Erlanson, Rachel Grainger, Wolfgang Jahnke, Joseph P. A. Harrity, Mark W. Davies, Iwan J. P. de Esch and Paul N. Mortenson and has published in prestigious journals such as Chemical Reviews, Chemical Communications and Journal of Medicinal Chemistry.

In The Last Decade

Christopher N. Johnson

40 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Brief Introduction to Chemical Reaction Optimization

2023 238 citations Connor J. Taylor, Alexander Pomberger et al. Chemical Reviews profile →

Peers

Christopher N. Johnson

CTM

ONCOL

Philippe G. Nantermet United States

Minoru Ishikawa Japan

Alleyn T. Plowright Sweden

Christian Peifer Germany

Wenjing Wang China

Zhaopeng Liu China

Dearg S. Brown United Kingdom

Jian Gao China

Asma M. Aman Canada

Junqi Li China

Philippe G. Nantermet United States

Christopher N. Johnson

354 ×0.4

707 ×1.1

234 ×0.8

CTM

80 ×0.4

ONCOL

200 ×1.1

Citations per year, relative to Christopher N. Johnson Christopher N. Johnson (= 1×) peers Philippe G. Nantermet

Countries citing papers authored by Christopher N. Johnson

Since Specialization

Citations

This map shows the geographic impact of Christopher N. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher N. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher N. Johnson more than expected).

Fields of papers citing papers by Christopher N. Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher N. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher N. Johnson. The network helps show where Christopher N. Johnson may publish in the future.

Co-authorship network of co-authors of Christopher N. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher N. Johnson. A scholar is included among the top collaborators of Christopher N. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher N. Johnson. Christopher N. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Arai, Kenta, Michelle R. Arkin, Daniel A. Erlanson, et al.. (2025). Fragment-to-Lead Medicinal Chemistry Publications in 2024: A Tenth Annual Perspective. Journal of Medicinal Chemistry. 68(23). 24830–24847.

Taylor, Connor J., Alexander Pomberger, Kobi Felton, et al.. (2023). A Brief Introduction to Chemical Reaction Optimization. Chemical Reviews. 123(6). 3089–3126. 238 indexed citations breakdown →

Taylor, Connor J., Kobi Felton, Daniel Wigh, et al.. (2023). Accelerated Chemical Reaction Optimization Using Multi-Task Learning. ACS Central Science. 9(5). 957–968. 64 indexed citations

Esch, Iwan J. P. de, et al.. (2021). Fragment-to-Lead Medicinal Chemistry Publications in 2020. Journal of Medicinal Chemistry. 65(1). 84–99. 68 indexed citations

Ward, George A., Edward J. Lewis, Jong Sook Ahn, et al.. (2018). ASTX660, a Novel Non-peptidomimetic Antagonist of cIAP1/2 and XIAP, Potently Induces TNFα-Dependent Apoptosis in Cancer Cell Lines and Inhibits Tumor Growth. Molecular Cancer Therapeutics. 17(7). 1381–1391. 53 indexed citations

Corser, William, et al.. (2018). Liposomal bupivacaine reduces opioid consumption and length of stay in patients undergoing primary total hip arthroplasty. Hip International. 29(3). 276–281. 6 indexed citations

Johnson, Christopher N., Alice S. Ha, Eleanor Y. Chen, & Darin Davidson. (2018). Lipomatous Soft-tissue Tumors. Journal of the American Academy of Orthopaedic Surgeons. 26(22). 779–788. 63 indexed citations

Tamanini, Emiliano, Ildiko M. Buck, Gianni Chessari, et al.. (2017). Discovery of a Potent Nonpeptidomimetic, Small-Molecule Antagonist of Cellular Inhibitor of Apoptosis Protein 1 (cIAP1) and X-Linked Inhibitor of Apoptosis Protein (XIAP). Journal of Medicinal Chemistry. 60(11). 4611–4625. 57 indexed citations

Lebraud, Honorine, David J. Wright, Christopher N. Johnson, & Tom D. Heightman. (2016). Protein Degradation by In-Cell Self-Assembly of Proteolysis Targeting Chimeras. ACS Central Science. 2(12). 927–934. 310 indexed citations

10.

Johnson, Christopher N., Daniel A. Erlanson, Christopher W. Murray, & David C. Rees. (2016). Fragment-to-Lead Medicinal Chemistry Publications in 2015. Journal of Medicinal Chemistry. 60(1). 89–99. 52 indexed citations

11.

Thompson, N., Mok‐Ryeon Ahn, Gianni Chessari, et al.. (2012). 85 Characterization of a Potent XIAP and CIAP1 Dual Antagonist in Models of Melanoma and Leukemia. European Journal of Cancer. 48. 27–27. 3 indexed citations

12.

Healy, Mark P., Gianpaolo Bravi, Andrew Billinton, et al.. (2010). Pyrazolopyridazine alpha-2-delta-1 ligands for the treatment of neuropathic pain. Bioorganic & Medicinal Chemistry Letters. 20(15). 4683–4688. 12 indexed citations

13.

Witty, David R., John H. Bateson, Guillaume Hervieu, et al.. (2006). Discovery of potent and stable conformationally constrained analogues of the MCH R1 antagonist SB-568849. Bioorganic & Medicinal Chemistry Letters. 16(18). 4872–4878. 18 indexed citations

14.

Martarello, Laurent, Maaz S. Ahmed, V J Cunningham, et al.. (2005). RADIOLABELLING AND IN VIVO EVALUATION OF [C-11]GSK215083 AS A POTENTIAL 5-HT6 PET RADIOLIGAND IN THE PORCINE BRAIN. Journal of Labelled Compounds and Radiopharmaceuticals. 48. 3 indexed citations

15.

Harrity, Joseph P. A., et al.. (2002). 5-Butyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(2,4,6-trimethylphenyl)isoxazole. Acta Crystallographica Section C Crystal Structure Communications. 58(3). o168–o169. 1 indexed citations

16.

Davies, Mark W., et al.. (2001). A regioselective cycloaddition route to isoxazoleboronic esters. Chemical Communications. 1558–1559. 46 indexed citations

17.

Austin, Nigel, Kim Y. Avenell, Izzy Boyfield, et al.. (2000). Novel 2,3,4,5-tetrahydro-1H-3-benzazepines with high affinity and selectivity for the dopamine D3 receptor. Bioorganic & Medicinal Chemistry Letters. 10(22). 2553–2555. 15 indexed citations

18.

Avenell, Kim Y., Izzy Boyfield, Michael S. Hadley, et al.. (1999). Heterocyclic analogues of 2-aminotetralins with high affinity and selectivity for the dopamine D3 receptor. Bioorganic & Medicinal Chemistry Letters. 9(18). 2715–2720. 14 indexed citations

19.

Austin, Nigel, Kim Y. Avenell, Izzy Boyfield, et al.. (1999). Novel 1,2,3,4-tetrahydroisoquinolines with high affinity and selectivity for the dopamine D3 receptor. Bioorganic & Medicinal Chemistry Letters. 9(2). 179–184. 15 indexed citations

20.

Boyfield, Izzy, Martyn C. Coldwell, Michael S. Hadley, et al.. (1996). Novel 2,5-disubstituted-1H-pyrroles with high affinity for the dopamine D3 receptor. Bioorganic & Medicinal Chemistry Letters. 6(11). 1233–1236. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact